Lista de obras - Carmine Carbone - Dominio Público Uruguay

A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer ⬇️

artículo científico publicado en 2016

A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma.

artículo científico publicado en 2017

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells

artículo científico publicado en 2013

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.

artículo científico publicado en 2014

An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.

artículo científico publicado en 2016

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.

artículo científico publicado en 2015

Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer.

artículo científico publicado en 2018

Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype.

artículo científico publicado en 2011

Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment

artículo científico publicado en 2015

Current Strategies to Overcome Resistance to ALK-Inhibitor Agents

artículo científico

EMT and Treatment Resistance in Pancreatic Cancer.

artículo científico publicado en 2017

Gut microbiome, big data and machine learning to promote precision medicine for cancer

artículo científico publicado en 2020

HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.

artículo científico publicado en 2011

Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients.

artículo científico publicado en 2017

Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease

artículo científico publicado en 2019

Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3

scientific article published on 18 September 2019

Induction of immunosuppressive functions and NF-κB by FLIP in monocytes

artículo científico publicado en 2018

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy.

artículo científico

Modulation of pancreatic cancer chemoresistance by inhibition of TAK1

artículo científico publicado en 2011

Molecular alterations in basal cell carcinoma subtypes

artículo científico publicado en 2021

Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimus.

artículo científico publicado en 2016

NF-κB as a target for pancreatic cancer therapy.

artículo científico

PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around

scientific article published on 09 August 2019

Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance

artículo científico publicado en 2018

Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation.

artículo científico publicado en 2018

Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia

artículo científico publicado en 2020

TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients

artículo científico publicado en 2015

Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.

artículo científico publicado en 2016

Tissue transglutaminase: a new target to reverse cancer drug resistance

artículo científico publicado en 2011

Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake

artículo científico publicado en 2019

Lista de obras de Carmine Carbone

A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer ⬇️

A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma.

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells

Acquired resistance to zoledronic acid and the parallel acquisition of an aggressive phenotype are mediated by p38-MAP kinase activation in prostate cancer cells.

An FGFR3 Autocrine Loop Sustains Acquired Resistance to Trastuzumab in Gastric Cancer Patients.

An angiopoietin-like protein 2 autocrine signaling promotes EMT during pancreatic ductal carcinogenesis.

Angiopoietin-Like Proteins in Angiogenesis, Inflammation and Cancer.

Anti-VEGF treatment-resistant pancreatic cancers secrete proinflammatory factors that contribute to malignant progression by inducing an EMT cell phenotype.

Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment

Current Strategies to Overcome Resistance to ALK-Inhibitor Agents

EMT and Treatment Resistance in Pancreatic Cancer.

Gut microbiome, big data and machine learning to promote precision medicine for cancer

HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT.

Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer Patients.

Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease

Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3

Induction of immunosuppressive functions and NF-κB by FLIP in monocytes

Mechanisms of resistance to chemotherapeutic and anti-angiogenic drugs as novel targets for pancreatic cancer therapy.

Modulation of pancreatic cancer chemoresistance by inhibition of TAK1

Molecular alterations in basal cell carcinoma subtypes

Molecular analysis of a male breast cancer patient with prolonged stable disease under mTOR/PI3K inhibitors BEZ235/everolimus.

NF-κB as a target for pancreatic cancer therapy.

PTEN in Lung Cancer: Dealing with the Problem, Building on New Knowledge and Turning the Game Around

Pancreatic Cancer and Obesity: Molecular Mechanisms of Cell Transformation and Chemoresistance

Predictive biomarkers for the treatment of resectable esophageal and esophago-gastric junction adenocarcinoma: from hypothesis generation to clinical validation.

Small Molecule Inhibitors of Microenvironmental Wnt/β-Catenin Signaling Enhance the Chemosensitivity of Acute Myeloid Leukemia

TAK1-regulated expression of BIRC3 predicts resistance to preoperative chemoradiotherapy in oesophageal adenocarcinoma patients

Tissue transglutaminase (TG2) is involved in the resistance of cancer cells to the histone deacetylase (HDAC) inhibitor vorinostat.

Tissue transglutaminase: a new target to reverse cancer drug resistance

Vorinostat Potentiates 5-Fluorouracil/Cisplatin Combination by Inhibiting Chemotherapy-Induced EGFR Nuclear Translocation and Increasing Cisplatin Uptake